Literature DB >> 19850008

Phosphatidylinositol-3-kinase-dependent phosphorylation of SLP-76 by the lymphoma-associated ITK-SYK fusion-protein.

Alamdar Hussain1, Rani Faryal, Beston F Nore, Abdalla J Mohamed, C I Edvard Smith.   

Abstract

Recurrent chromosomal translocations have long been implicated in various types of lymphomas and other malignancies. Novel recurrent t(5;9)(q33;q22) has been recently discovered in un-specified peripheral T-cell lymphoma. To elucidate the role of this translocation, the corresponding fusion construct encoding the N-terminal portion of the ITK kinase and the C-terminal catalytic region of the SYK kinase was generated. We herein show that the ITK-SYK fusion-protein is constitutively active. Moreover, we demonstrate that ITK-SYK is phosphorylated on key tyrosine residues and is capable of potently phosphorylating the related adapter proteins BLNK and SLP-76. In transiently transfected cells, SYK was phosphorylated at Y352 but not detectably at the activation-loop tyrosines Y525/Y526. In contrast, ITK-SYK was phosphorylated both at Y212 and the activation-loop tyrosines Y385/Y386, corresponding to Y352 and Y525/Y526 in SYK, respectively. In resting primary lymphocytes, ITK-SYK predominantly localizes to the cell surface. In addition, we demonstrate that following stimulation, the ITK-SYK fusion-protein in cell lines translocates to the cell membrane and, moreover, that this phenomenon as well as SLP-76 phosphorylation are blocked upon phosphatidylinositol-3-kinase (PI3-kinase) inhibition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850008     DOI: 10.1016/j.bbrc.2009.10.070

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Signaling of the ITK (interleukin 2-inducible T cell kinase)-SYK (spleen tyrosine kinase) fusion kinase is dependent on adapter SLP-76 and on the adapter function of the kinases SYK and ZAP70.

Authors:  Alamdar Hussain; Dara K Mohammad; Manuela O Gustafsson; Merve Uslu; Abdulrahman Hamasy; Beston F Nore; Abdalla J Mohamed; C I Edvard Smith
Journal:  J Biol Chem       Date:  2013-01-04       Impact factor: 5.157

2.  Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases.

Authors:  Yiming Zhong; Amy J Johnson; John C Byrd; Jason A Dubovsky
Journal:  Postdoc J       Date:  2014-06

3.  Challenging perspectives on the cellular origins of lymphoma.

Authors:  Tim I M Malcolm; Daniel J Hodson; Elizabeth A Macintyre; Suzanne D Turner
Journal:  Open Biol       Date:  2016-09       Impact factor: 6.411

4.  Genome profiling revealed the activation of IL2RG/JAK3/STAT5 in peripheral T‑cell lymphoma expressing the ITK‑SYK fusion gene.

Authors:  Lei-Lei Zhang; Hua-Xiong Pan; Yi-Xuan Wang; Tao Guo; Lin Liu
Journal:  Int J Oncol       Date:  2019-09-20       Impact factor: 5.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.